This invention describes a contact lens designed to release medication directly into the eye. It achieves this by having a special coating on its surface, rather than the drug being mixed into the lens material itself. This coating contains the medication and is structured with layers and tiny channels to control how the drug is released, specifically to help treat or prevent myopia.
Why it matters: Precision printing technologies for micro-scale drug delivery systems have matured significantly since 2019, potentially making the complex multi-layered coatings and capillary structures described more feasible to manufacture on contact lenses. Additionally, research into non-invasive myopia control has intensified, creating a stronger demand for effective, sustained-release ocular treatments.
AI gives you a few directions you could take this. Pick one, and we check whether your version is different enough to patent, then write the filing.
Reinvent this with AI